Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
GILDGilead Sciences
FinDog View：Neutral
| Metric | CRL | GILD |
|---|
| Close | 273.41 | 147.68 |
| Market Cap | $13.1B | $183B |
| 1M | −4.62% | +6.31% |
| P/E (TTM) | — | — |
| Forward P/E | 24.2 | 25.3 |
| P/E 5-Yr Percentile | — | — |
| P/S | 3.3 | 6.0 |
| P/B | 4.6 | 15.3 |
| Dividend Yield | — | 3.98% |
| Latest Quarter Revenue | $1.0B | $7.8B |
| Revenue YoY | −2.7% | +10.2% |
| Gross Margin | — | 79.8% |
| Latest Quarter EPS | -0.03 | -8.45 |
| Avg Post-Earnings Move | ±1.8% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.48% | 3.01% |
| 90-Day Net Insider Buying | −$42.6M | −$15.4M |
CRL · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
